Bio-Techne (TECH) Shares Outstanding (Weighted Average) (2009 - 2026)

Bio-Techne's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $155.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 1.41% year-over-year to $155.9 million; the TTM figure through Mar 2026 stood at $155.9 million (down 1.41% YoY), while the FY2025 annual figure was $157.5 million, changed 0.12% from the prior year.
• Shares Outstanding (Weighted Average) was $155.9 million for Q1 2026 at Bio-Techne, roughly flat from $155.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $158.5 million in Q3 2024 to a low of $155.5 million in Q3 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $157.2 million across 5 years, with a median of $157.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) soared 304.28% in 2022, then declined 1.93% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $156.9 million in 2022, then advanced by 0.41% to $157.5 million in 2023, then rose by 0.6% to $158.5 million in 2024, then retreated by 1.67% to $155.8 million in 2025, then gained by 0.03% to $155.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $155.9 million (Q1 2026), $155.8 million (Q4 2025), and $155.5 million (Q3 2025), per Business Quant data.